Mcf Advisors LLC Abbott Laboratories Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Mcf Advisors LLC holds 4,084 shares of ABT stock, worth $473,335. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,084

Previous 4,442 8.06%

Holding current value

$473,335

Previous $461,000 0.87%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $35,825 - $42,290	-358 Reduced 8.06%	4,084 $465,000
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $73,129 - $81,631	-726 Reduced 14.05%	4,442 $461,000
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $12,375 - $13,668	-113 Reduced 2.14%	5,168 $587,000
Q4 2023 Feb 01, 2024	BUY	$90.19 - $110.4 $29,492 - $36,100	327 Added 6.6%	5,281 $581,000
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $3,152 - $3,782	-33 Reduced 0.66%	4,954 $479,000
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $138,572 - $154,398	1,375 Added 38.07%	4,987 $543,000
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $12,688 - $14,935	-131 Reduced 3.5%	3,612 $365,000
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $8,745 - $10,259	92 Added 2.52%	3,743 $411,000
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $15,578 - $18,036	161 Added 4.61%	3,651 $353,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $73,592 - $88,949	721 Added 26.04%	3,490 $379,000
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $315,721 - $385,001	2,769 New	2,769 $327,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $293,792 - $359,732	-2,543 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $11,432 - $12,647	98 Added 4.01%	2,543 $300,000
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $62,098 - $73,099	587 Added 31.59%	2,445 $283,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $94,364 - $111,175	867 Added 87.49%	1,858 $223,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $43,260 - $47,141	-412 Reduced 29.37%	991 $109,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $36,289 - $44,070	396 Added 39.32%	1,403 $153,000
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $248,086 - $317,520	-3,240 Reduced 76.29%	1,007 $92,000
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $21,590 - $24,035	275 Added 6.92%	4,247 $369,000
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $81,840 - $88,740	1,000 Added 33.65%	3,972 $332,000
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $8,599 - $10,030	118 Added 4.13%	2,972 $250,000
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $29,136 - $35,226	-440 Reduced 13.36%	2,854 $228,000
Q4 2018 Jan 25, 2019	SELL	$65.56 - $74.27 $8,457 - $9,580	-129 Reduced 3.77%	3,294 $238,000
Q3 2018 Oct 24, 2018	SELL	$60.81 - $73.36 $207,787 - $250,671	-3,417 Reduced 49.96%	3,423 $251,000
Q2 2018 Jul 20, 2018	BUY	$57.57 - $63.54 $196,946 - $217,370	3,421 Added 100.06%	6,840 $414,000
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $7,427 - $8,397	132 Added 4.02%	3,419 $205,000
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $107 - $114	2 Added 0.06%	3,287 $188,000
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $157,877 - $176,207	3,285	3,285 $175,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account